NovoCure Past Earnings Performance

Past criteria checks 0/6

NovoCure's earnings have been declining at an average annual rate of -41.4%, while the Medical Equipment industry saw earnings growing at 12.3% annually. Revenues have been growing at an average rate of 14.5% per year.

Key information

-41.4%

Earnings growth rate

-37.7%

EPS growth rate

Medical Equipment Industry Growth12.9%
Revenue growth rate14.5%
Return on equity-50.1%
Net Margin-39.1%
Last Earnings Update30 Sep 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How NovoCure makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BMV:NVCR N Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 23504-197380224
30 Jun 23508-174354222
31 Mar 23522-141331224
31 Dec 22538-93306206
30 Sep 22543-82289208
30 Jun 22545-68279204
31 Mar 22538-59269198
31 Dec 21535-58263201
30 Sep 21546-27253188
30 Jun 21545-5246173
31 Mar 2152712232153
31 Dec 2049420225132
30 Sep 2045019216112
30 Jun 204091220698
31 Mar 20380919787
31 Dec 19351-718579
30 Sep 19322-2717470
30 Jun 19294-4116665
31 Mar 19269-5515857
31 Dec 18248-6415151
30 Sep 18232-5914346
30 Jun 18217-5913742
31 Mar 18194-6413140
31 Dec 17177-6212338
30 Sep 17154-7311537
30 Jun 17125-9511237
31 Mar 17105-11410839
31 Dec 1683-13210741
30 Sep 1665-14310844
30 Jun 1652-1359644
31 Mar 1641-1248545
31 Dec 1533-1127344
30 Sep 1525-1026044
30 Jun 1520-945343
31 Mar 1518-864941
31 Dec 1415-814540
31 Dec 1310-773335

Quality Earnings: NVCR N is currently unprofitable.

Growing Profit Margin: NVCR N is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: NVCR N is unprofitable, and losses have increased over the past 5 years at a rate of 41.4% per year.

Accelerating Growth: Unable to compare NVCR N's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: NVCR N is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-3%).


Return on Equity

High ROE: NVCR N has a negative Return on Equity (-50.11%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies